VideoHIVViral Hepatitis and Liver DiseaseAPACC 2016Integrating PrEP in prevention | Robert Grant, MD, MPHView Video
SLShui-Shan LeeMD, FRCP, FRCPA, FFPHVideoHIVViral Hepatitis and Liver DiseaseAPACC 2016Transmission networks among MSM | Shui-Shan Lee, MD, FRCP, FRCPA, FFPHView Video
PYLPhilip Yi-Chun LoMDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2016HIV surveillance – Are we missing out on key populations? | Ying-Ru Lo, MDView Video
JAJintanat AnanworanichMD, PhDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2016Towards an HIV Cure; clinical strategies and trials | Jintanat Ananworanich, MD, PhDView Video
SLSharon LewinAO, FRACP, PhD, FAHMSVideoHIVViral Hepatitis and Liver DiseaseAPACC 2016Towards an HIV Cure; understanding the major barriers | Sharon Lewin, AO, FRACP, PhD, FAHMSView Video
MNMark NelsonMD, MBBS, FRCPSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Clinical case presentation | Mark Nelson, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Development of HIV Vaccine Candidates for Prevention and Treatment | Sandhya Vasan, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Sofosbuvir and Ribavirin therapy for the Treatment of HIV/HCV co-infected patients with HCV GT1-4 Infection: The PHOTON-1 and -2 Trials|||| Ledipasvir/Sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1 | Dr. J. RockstrohView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Metabolic Syndrome among Malaysian HIV-Infected Patients: Preliminary Results from the HIV & Ageing Cohort | Sivaraj Naidu, MMedScView Slideset
